Mednax a turnaround play – Hedgeye

Hedgeye’s Thomas Tobin adds Mednax (NYSE:MD) to his best idea list (on the long side), suggesting as much as 60% upside.

“Modest but critical” improvements should lead to a turnaround next year, says Tobin.

An $80-plus stock a few years back, Mednax has steadily drifted lower to its current $28. Tobin sees shares maybe rising to nearly $45.

https://seekingalpha.com/news/3528242-mednax-turnaround-play-hedgeye